Get startedLog in
    Picture of AstraZeneca logo

    AZN — AstraZeneca News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Astrazeneca Says Klygefa Recommended For EU Approval To Treat Adults With Generalized Myasthenia Gravis

    Picture of AstraZeneca logoAstraZeneca
    18/09/2026 14:10
    BRIEF-Astrazeneca Says Klygefa Recommended For EU Approval To Treat Adults With Generalized Myasthenia Gravis
    Sept 18 (Reuters) - AstraZeneca PLC AZN.L:
    • ASTRAZENECA: KLYGEFA (GEFURULIMAB) RECOMMENDED FOR APPROVAL IN EU BY CHMP FOR TREATMENT OF ADULTS WITH GENERALISED MYASTHENIA GRAVIS (GMG)
    Source text: [ID:]
    Further company coverage: AZN.L

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on AstraZeneca

    See all news